Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) Return on Sales (2016 - 2025)

Skinvisible's Return on Sales history spans 16 years, with the latest figure at 50.05% for Q3 2025.

  • For Q3 2025, Return on Sales rose 850.0% year-over-year to 50.05%; the TTM value through Sep 2025 reached 58.88%, up 92.0%, while the annual FY2024 figure was 62.95%, 5592.0% up from the prior year.
  • Return on Sales for Q3 2025 was 50.05% at Skinvisible, up from 55.79% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.28% in Q4 2021 and bottomed at 302.4% in Q1 2023.
  • The 5-year median for Return on Sales is 56.07% (2023), against an average of 55.76%.
  • The largest annual shift saw Return on Sales crashed -29625bps in 2023 before it soared 24449bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.28% in 2021, then plummeted by -28734bps to 81.78% in 2022, then increased by 26bps to 60.86% in 2023, then decreased by -21bps to 73.48% in 2024, then soared by 32bps to 50.05% in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Return on Sales are 50.05% (Q3 2025), 55.79% (Q2 2025), and 56.2% (Q1 2025).